Cite
MLA Citation
Muhammad Bilal Abid et al.. “Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?.” Hematological oncology, vol. 36, no. 1, 2018, pp. 320–323. http://access.bl.uk/ark:/81055/vdc_100057158818.0x000060